1,019 filings
Page 2 of 51
DFAN14A
iycc22 q8df
15 Feb 24
Additional proxy materials by non-management
5:23pm
DFAN14A
j54zq 7lmg
29 Jan 24
Additional proxy materials by non-management
4:50pm
8-K
6fz 4qwxil
23 Jan 24
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
7:45am
DFAN14A
m8c1l
9 Jan 24
Additional proxy materials by non-management
5:08pm
DFAN14A
qpqzj
8 Jan 24
Additional proxy materials by non-management
5:22pm
DEFA14A
qve0w95p
8 Jan 24
Additional proxy soliciting materials
8:22am
8-K
dmyc0vwkjudyg73yf 7w
5 Dec 23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
4:42pm
8-K
ciytm7
5 Dec 23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
7:52am
8-K
xw3wry zm9cp7yn7t
30 Nov 23
Strengthens position in high-growth MedTech segments
4:30pm
8-K
ey2ogtb52
27 Nov 23
Departure of Directors or Certain Officers
4:56pm
8-K
ltjre1ryr72gkcpu
23 Oct 23
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
4:48pm
8-K
2vrxq5qg
17 Oct 23
Results of Operations and Financial Condition
7:33am
8-K
vm5a8 6xm
30 Aug 23
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
7:46am
8-K
hrw ushpl
25 Aug 23
Completion of Acquisition or Disposition of Assets
5:02pm
SC TO-I/A
bkfip1b 1n54j2wus92
23 Aug 23
Issuer tender offer statement (amended)
7:04am
425
5qr054pm q4o6s9h4lnw
23 Aug 23
Business combination disclosure
6:37am
SC TO-I/A
dbj3ro49wm4b1
21 Aug 23
Issuer tender offer statement (amended)
6:52am